Response by Gargiulo et al to Letter Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment–Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial". Issue 13 (30th March 2021) - Gargiulo, Giuseppe; Nagler, Michael; Valgimigli, Marco